Chemoinformaics analysis of trans-13-Cinnamoyloxylupanine
Molecular Weight | 394.515 | nRot | 3 |
Heavy Atom Molecular Weight | 364.275 | nRig | 29 |
Exact Molecular Weight | 394.226 | nRing | 5 |
Solubility: LogS | -4.336 | nHRing | 4 |
Solubility: LogP | 3.288 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 4 |
No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 64.6898 |
nHD | 0 | BPOL | 36.9882 |
QED | 0.582 |
Synth | 4.733 |
Natural Product Likeliness | 0.811 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.159 |
Pgp-sub | 0.034 |
HIA | 0.496 |
CACO-2 | -4.87 |
MDCK | 0.0000826 |
BBB | 0.947 |
PPB | 0.853216 |
VDSS | 1.232 |
FU | 0.134024 |
CYP1A2-inh | 0.065 |
CYP1A2-sub | 0.156 |
CYP2c19-inh | 0.1 |
CYP2c19-sub | 0.252 |
CYP2c9-inh | 0.048 |
CYP2c9-sub | 0.951 |
CYP2d6-inh | 0.936 |
CYP2d6-sub | 0.859 |
CYP3a4-inh | 0.208 |
CYP3a4-sub | 0.815 |
CL | 6.723 |
T12 | 0.398 |
hERG | 0.036 |
Ames | 0.01 |
ROA | 0.024 |
SkinSen | 0.949 |
Carcinogencity | 0.243 |
EI | 0.035 |
Respiratory | 0.337 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.693078 |